Winner

Canaquest Medical Corp

Best Global Medical Cannabinoid Development Company 2023

Healthcare & Pharmaceuticals Awards - 2023

winners chosen image

Canaquest Medical Corp

Healthcare & Pharmaceuticals Awards - 2023

Best Global Medical Cannabinoid Development Company 2023

New Pathway Discovery into the Brain for Mental Wellbeing

Pre-clinical trials demonstrated that Mentanine can help people with anxiety, depression, and PTSD.

The neuroscience team combined cannabidiol “CBD” with Omega-3, DHA, and EPA molecules. The molecules bonded and synergistically attached to the Nuclear PPAR receptor, which allowed the formula to effectively cross the blood-brain barrier “BBB” to the section of the brain that regulates emotions. i.e. depression.

See Canaquest Medical Corp's website